Iron transport-mediated drug delivery using mixed-ligand siderophore- β-lactam conjugates

Chemistry and Biology

Volumn 3, Issue 12, 1996, Pages 1011-1019

  Ghosh, Arun ^a   Ghosh, Manuka ^a   Niu, Chuan ^a   Malouin, François ^b,c,e   Moellmann, Ute ^d   Miller, Marvin J ^a  

^a UNIVERSITY OF NOTRE DAME   (United States)

^b UNIVERSITÉ LAVAL   (Canada)

^c LAVAL UNIVERSITY   (Canada)

^d HANS KNÖLL INSTITUTE   (Germany)

^e Microcide Pharmaceuticals   (United States)

Author keywords

antibiotics; conjugates; iron; siderophores; lactams

Indexed keywords

EID: 0030453553     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-5521(96)90167-2     Document Type: Article

References (26)

1. Koshland, D.E., Jr. (1994). The biological warfare of the future. Science 254, 327.
2. Travis, J. (1994). Reviving the antibiotic miracle? Science 254, 360-362.
3. Nikaido, H. (1994). Prevention of drug access to bacterial targets: permeability barriers and active efflux. Science 254, 382-388.
4. Spratt, B.G. (1994). Resistance to antibiotics mediated by target alterations. Science 254, 388-393.
5. Davies, J. (1994). Inactivation of antibiotics and the dissemination of resistance genes. Science 254, 375-381.
6. Winkelmann, G., van der Helm, D. & Neilands, J.B., eds. (1987). Iron transport in microbes, plants and animals. VCH, Weinheim, FRG.
7. Hider, R.C. (1984). Siderophore-mediated absorption of iron. Struct. Bonding 58, 1-25.
8. 5-hydroxyl-L-ornithine. Liebigs Ann, Chem. 1434-1444.
9. 5-hydroxy-L-ornithine derived siderophore-carbacephalosporin β-lactam conjugates: iron transport mediated drug delivery. J. Med. Chem. 33, 461-464.
10. McKee, J.A., Sharma, S.K. & Miller, M.J. (1991). Iron transport mediated drug delivery systems: synthesis and antibacterial activity of spermidine- and lysine-based siderophore-β-lactam conjugates. Bioconj. Chem. 2, 281-291.
11. Miller, M.J., et. al., & Teng, M. (1993). Iron transport-mediated drug delivery. In Recent Advances in the Chemistry of Anti-Infective Agents, Special Publication, No. 119 (Bentley P.H. & Ponsford, R. eds), pp. 135-159, Royal Society of Chemistry, London, UK.
12. Miller, M. J. & Malouin, F. (1993). Microbial iron chelators as drug delivery agents: the rational design and synthesis of siderophore-drug conjugates. Accts. Chem. Res. 26, 241-249.
13. Brochu, A., Brochu, N., Nicas, T.I., Parr, T.R. Jr., Miller, M.J. & Malouin, F. (1992). Modes of action and inhibitory activities of new siderophore-β-lactam conjugates that use specific iron uptake pathways for entry into bacteria. Antimicrob. Agents Chemother. 36, 2166-2175.
14. Minnick, A.A., McKee, J.A., Dolence, E.K., Miller, M.J. (1992). Iron transport-mediated antibacterial activity of and development of resistance to hydroxamate and catechol siderophore-carbacephalosporin conjugates. Antimicrob. Agents Chemother. 36, 840-850.
15. Ghosh, A. & Miller, M.J. (1993). Synthesis of novel citrate-based siderophores and siderophore-β-lactam conjugates. Iron transport-mediated drug delivery systems. J. Org. Chem. 58, 7652-7659.
16. Bodurow, C.C., et al., & Vladuchick, W.C. (1989). An enantioselective synthesis of Loracarbef (LY 68921/KT3777). Tetrahedron Lett. 30, 2321-2324.
17. ε-hydroxy-L-lysine, the iron-binding constituent of several important siderophores. J. Org. Chem. 59, 4858-4861.
18. Neu, H.C. (1987). The role of β-lactamase inhibitors in chemotherapy. In Antibiotic inhibitors of bacterial cell wall synthesis. (Tipper, D.J. ed.), pp. 241-258, Int. Encyclopedia of Phamacology and Therapeutics, Pergamon Press.
19. Hantke, K. (1990). Dihydroxybenzoylserine - a siderophore for E. coli. FEMS Microbiol Lett. 67, 5-8.
20. Diarra, M.S., et al., & Jacques, M. (1996). Structure-activity relationship studies of new siderophore-drug conjugates that use specific iron uptake for entry into bacteria. Antimicrob. Agents Chemother. 40, 2610-2617.
21. Derome, A.E. (1987). Modern NMR Techniques for Chemistry and Research. Pergamon, NY, USA.
22. Gordon, A.J. & Ford, R.A. (1972). The chemists companion - a handbook of practical data, techniques and references, pp. 408-456. John Wiley and Sons, New York, USA.
23. Kirst, H.A., et al., & Ose, E.E. (1982). Structure-activity studies among 16-membered macrolide antibiotics related to tylosin. J. Antibiot. (Tokyo) 35, 1675-1682.
24. Richmond, M.H., Clark, D.C. & Wolton, S. (1976). Indirect method for assessing the penetration of β-lactamase-nonsusceptible penicillins and cephalosporins in Escherichia coli strains. Antimicrob. Agents Chemother. 10, 215-218.
25. Zimmerman, W. (1979). Penetration through the Gram-negative cell wall: a co-determinant of efficacy of β-lactam antibiotics. J. Clin. Pharmacol. Biopharm. 17, 131-134.
26. Reissbrodt, R., Heinisch, L., Moellmann, U. & Rabsch, W. (1993). Growth promotion of synthetic catecholate derivatives on Gram-negative bacteria. Biobetals 6, 155-162.